NewAmsterdam Pharma Co N.V. - Ordinary Shares, Nominal value 0.12 per share (NAMS)

Historical Holders from Q4 2022 to Q3 2025

Symbol
NAMS on Nasdaq
CUSIP
N62509109
Type / Class
Equity / Ordinary Shares, Nominal value 0.12 per share
Shares outstanding
112M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
116M
Holdings value
$2.11B
% of all portfolios
0.01%
Grand Portfolio weight change
+0%
Number of holders
130
Number of buys
82
Number of sells
-50
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NewAmsterdam Pharma Co N.V. - Ordinary Shares, Nominal value 0.12 per share (NAMS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 9.9% 0% $167M $2.84M 11.1M +1.73% RA Capital Management, L.P. Mar 31, 2025
Forbion Capital Fund IV Cooperatief U.A. 8.3% -12.2% $223M -$30.2M 9.32M -11.9% ForGrowth NAP B.V. Sep 26, 2025
Capital World Investors 7.5% +21.7% $201M $38.1M 8.39M +23.4% Capital World Investors Jun 30, 2025
Frazier Life Sciences X, L.P. 6.5% $176M 7.33M Frazier Life Sciences X, L.P. Aug 18, 2025
VIKING GLOBAL INVESTORS LP 6.5% $106M 6.98M VIKING GLOBAL INVESTORS LP Dec 31, 2024

Institutional Holders of NewAmsterdam Pharma Co N.V. - Ordinary Shares, Nominal value 0.12 per share (NAMS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1.39K $39.6K +$32.1K $28.44 2
2025 Q2 116M $2.11B +$92.2M $18.11 130
2025 Q1 111M $2.28B +$248M $20.47 126
2024 Q4 98.6M $2.53B +$570M $25.70 130
2024 Q3 77.1M $1.28B +$65.9M $16.60 102
2024 Q2 72M $1.38B -$7.86M $19.21 90
2024 Q1 72.2M $1.71B +$239M $23.65 76
2023 Q4 61.9M $691M -$381K $11.17 32
2023 Q3 50.2M $464M +$5.44M $9.25 35
2023 Q2 48.8M $581M +$184M $11.89 29
2023 Q1 33.3M $445M +$689K $13.26 20
2022 Q4 33.5M $362M +$362M $10.90 14